This is the first time a regulator has confirmed the side effect. Read more at straitstimes.com. Read more at straitstimes.com.

Ozempic and Wegovy, used for diabetes and weight loss, are now linked to a rare eye condition called NAION, or "eye stroke." ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

European Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide ...

Ozempic and other GLP-1 drugs have forever altered the way people view, manage, and speak about obesity. However, it’s ...

The European Medicines Agency warns that Novo Nordisk's Ozempic and Wegovy may, in rare cases, cause NAION—a serious eye condition that can lead to vision loss. The EMA has asked the company to update ...